KDM5A and breast carcinoma: Moreover, our cytotoxicity assay results indicated that compound 1 could repress the growth of KDM5A-overexpressing breast cancer cell lines, with subsequent KD5MA knockdown experiments demonstrating that the anti-proliferative effect of 1 likely results from its inhibitory activity against KDM5A.